{"id":"W3091858640","doi":"10.1080/14756366.2020.1825408","title":"Design of new disubstituted imidazo[1,2-<i>b</i>]pyridazine derivatives as selective Haspin inhibitors. Synthesis, binding mode and anticancer biological evaluation","year":2020,"lang":"en","type":"article","venue":"Journal of Enzyme Inhibition and Medicinal Chemistry","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; Meso Scale Diagnostics; Janssen Biotech; Innovative Medicines Initiative; Ministero dello Sviluppo Economico; Région Bretagne; Labex; AbbVie; Novartis Pharma; Deutschen Konsortium für Translationale Krebsforschung; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Agence Nationale de la Recherche; Wellcome Trust; Cancéropôle Grand Ouest; Fundação de Amparo à Pesquisa do Estado de São Paulo; Diamond Light Source; Genome Canada; Takeda Pharmaceutical Company; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; Pfizer; Ligue Contre le Cancer; Boehringer Ingelheim","keywords":"Pyridazine; Chemistry; Stereochemistry; Combinatorial chemistry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007114682,0.0001887035,0.0005476682,0.00008742322,0.00005866553,0.00001692812,0.00005689794,0.0001661609,0.0001831558],"category_scores_gemma":[0.003247888,0.0001399387,0.00007100159,0.0002961708,0.0003541702,0.0001456535,0.00004493324,0.0004170887,0.000001466146],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008968399,"about_ca_system_score_gemma":0.003477122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002920712,"about_ca_topic_score_gemma":3.334344e-7,"domain_scores_codex":[0.9980341,0.00009485564,0.0006200639,0.0002494422,0.0007836881,0.000217847],"domain_scores_gemma":[0.9981884,0.0003328054,0.0004114625,0.00008450509,0.000465644,0.000517222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002029513,0.00009017894,0.0003822209,0.0003527768,0.0001316566,0.0001307968,0.0009607121,0.0001603534,0.9921657,0.00001361445,0.001432043,0.002150478],"study_design_scores_gemma":[0.009177028,0.0007477808,0.0004338965,0.001404107,0.0002749542,0.001472155,0.0008709297,0.0101299,0.9751484,0.0001344676,0.00007330963,0.0001330778],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923533,0.002097877,0.002628205,0.002342921,0.00003507684,0.0002877402,0.000004645129,0.00001291494,0.0002373689],"genre_scores_gemma":[0.9971623,0.001136741,0.000811422,0.0002491391,0.000594825,0.000007150806,0.000009847859,0.00001446632,0.00001411048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01701727,"threshold_uncertainty_score":0.6168265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07055397884432821,"score_gpt":0.3443127778255069,"score_spread":0.2737587989811787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}